Trial site
Brain Research Center Amsterdam B.V.
- 18running trials
- 16closed trials
The trials here
What the 34 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease22 trials
- Parkinson disease6 trials
- Mild cognitive impairment4 trials
- Depression1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Lewy body dementia1 trial
- Obesity1 trial
- Sjögren's disease1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 213 trials
- Phase 311 trials
- Phase 17 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Status
- Completed16 trials
- Recruiting9 trials
- Active, not recruiting5 trials
- Not yet recruiting4 trials
- Lead sponsor
- Hoffmann-La Roche4 trials
- Alnylam Pharmaceuticals2 trials
- Biogen2 trials
- Bristol-Myers Squibb2 trials
- F. Hoffmann-La Roche AG2 trials
- and 21 more
Running trials
Recruiting
Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
Recruiting
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Recruiting
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Recruiting
Active, not recruiting
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
Recruiting
Recruiting
Recruiting
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease7 recruiting
- Parkinson disease3 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Sjögren's disease1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
A clinical trial to learn about the effects of VHB937 in people with Alzheimer's disease
Active, not recruiting
Recruiting
Recruiting
Completed
Completed
EFFICACY AND SAFETY OF GSK4527226 [AL101] IN PATIENTS WITH EARLY ALZHEIMER’S DISEASE
Completed
Completed
Completed
Completed
A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD)
Completed
GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)
Completed
Completed
Completed
Completed
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Site data: ClinicalTrials.govUpdated 12 Nov 2026